Nikon contributed to a $270m round valuing the DNA sequencing eqiupment producer at $3.4bn as it prepares to pursue a public listing.

Oxford Nanopore, a UK-based DNA sequencing technology spinout of University of Oxford, secured £195m ($270m) in equity financing today from investors including imaging technology producer Nikon.

IP Group, Temasek, Wellington Management and M&G Investment also took part in the round, alongside unnamed existing backers, at a valuation of $3.4bn.

Founded in 2005, Oxford Nanopore has developed DNA and RNA sequencing technology which provides analytics in real time. It is fully scalable from handheld devices for use in the field, through…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?